MERSANA THERAPEUTICS INC (MRSN) Institutional Ownership

None of the superinvestors we track currently report MERSANA THERAPEUTICS INC (MRSN) in their latest SEC Form 13F filings.

13F filings cover institutional equity holdings and are reported quarterly with a delay. This stock may still have insider Form 4 activity or appear in future filings.

When tracked funds report positions in MERSANA THERAPEUTICS INC (MRSN), this page will show institutional ownership trends, hedge fund exposure, portfolio concentration, historical 13F filings, and estimated holding performance.

Institutional Ownership Trend

Portfolio quarterInstitutional holdersTotal reported valueTotal shares
Q2 20251$843,6572,850,194
Q1 20251$289,100839,919
Q4 20241$866,988606,285
Q3 20241$931,239492,719
Q2 20241$2,910,9201,448,219
Q1 20241$6,3971,427,819
Q4 20231$2,008865,731
Q3 20231$1,176925,919
Q2 20231$3,4481,047,919
Q1 20231$5,1401,250,519
Q4 20221$3,350571,719
Q3 20221$4,724698,819